Gevo, a renewable chemicals and next-generation biofuels company, today reported that it has received a new patent from the U.S. Patent Office covering the company’s foundational methods for producing low-cost isobutanol at commercially relevant titer, productivity, and yields.
The ‘374 Patent protects the company’s strategy of converting existing ethanol plants into bio-refineries to make isobutanol, a naturally occurring four-carbon alcohol.
“This is a milestone achievement toward our goal of making commercial isobutanol a reality,” Brett Lund, Gevo’s executive vice president and general counsel stated in the press release. “This patent significantly strengthens Gevo’s intellectual property position and reinforces our unmatched ability to obtain dramatic improvements in commercially-viable isobutanol production. We will continue to take the steps necessary to protect and maintain the integrity of our industry-leading technology.”
This is the tenth U.S. patent granted to Gevo within its biocatalyst portfolio. Gevo’s comprehensive patent portfolio includes more than 450 patents and patent applications.
Gevo is slated to release its first-quarter financial results today after market close. Analysts expect the company to report a quarterly loss of $0.40 per share on revenues of $900,000.
For more information, visit www.gevo.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
